- Home
- HCM vs RSI Comparison
HCM vs RSI Comparison
Compare HCM & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCM | RSI |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HCM | RSI |
|---|---|---|
| Price | $14.01 | $19.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 12 |
| Target Price | $22.01 | ★ $35.67 |
| AVG Volume (30 Days) | 52.5K | ★ 3.3M |
| Earning Date | 07-30-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 933.33 |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $1,134,428,000.00 |
| Revenue This Year | $14.24 | $39.86 |
| Revenue Next Year | $11.52 | $15.96 |
| P/E Ratio | ★ $5.49 | $106.95 |
| Revenue Growth | N/A | ★ 22.76 |
| 52 Week Low | $9.77 | $15.51 |
| 52 Week High | $16.33 | $34.53 |
Technical Indicators
Market Signals| Indicator | HCM | RSI |
|---|---|---|
| Relative Strength Index (RSI) | 53.37 | 28.67 |
| Support Level | $13.70 | $19.10 |
| Resistance Level | $14.44 | $19.88 |
| Average True Range (ATR) | 0.30 | 1.03 |
| MACD | -0.09 | 0.06 |
| Stochastic Oscillator | 39.44 | 2.88 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.